Filters: Author is O'Connor, Patrick G [Clear All Filters]
"Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence." Journal of substance abuse treatment 33, no. 4 (2007): 411-5. Abstract
"A trial of integrated buprenorphine/naloxone and HIV clinical care." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S184-90. Abstract
"Treatment of heroin dependence with buprenorphine in primary care." The American journal of drug and alcohol abuse 28, no. 2 (2002): 231-41. Abstract
"Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction." Annals of internal medicine 146, no. 2 (2007): 116-27. Abstract
"A staging system to predict prognosis among methadone maintenance patients, based on admission characteristics." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 23, no. 4 (2002): 233-44. Abstract
"Risk for delirium tremens in patients with alcohol withdrawal syndrome." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 23, no. 2 (2002): 83-94. Abstract
"Reducing Bias in Observational Research on Alcohol Withdrawal Syndrome." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 19, no. 1 (1998): 23-31. Abstract
"A randomized trial of primary intensive care to reduce hospital admissions in patients with high utilization of inpatient services." Disease management : DM 9, no. 6 (2006): 328-38. Abstract
"A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine." The American journal of medicine 126, no. 1 (2013): 74.e11-7. Abstract
"Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses." Alcoholism, clinical and experimental research 30, no. 1 (2006): 70-5. Abstract
"Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13 Suppl 1 (2004): S67-78. Abstract
"Primary Care-Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical Trial." JAMA internal medicine (2014). Abstract
"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients." Journal of general internal medicine 22, no. 4 (2007): 527-30. Abstract
"The prevalence and impact of alcohol problems in major depression: a systematic review." The American journal of medicine 118, no. 4 (2005): 330-41. Abstract
"The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?" Drug and alcohol dependence 79, no. 1 (2005): 113-6. Abstract
"Patient satisfaction with primary care office-based buprenorphine/naloxone treatment." Journal of general internal medicine 22, no. 2 (2007): 242-5. Abstract
"Opioids, chronic pain, and addiction in primary care." The journal of pain : official journal of the American Pain Society 11, no. 12 (2010): 1442-50. Abstract
"Opioid Dependence Treatment in the Emergency Department--Reply." JAMA 314, no. 8 (2015): 835.
"New federal initiatives to enhance the medical treatment of opioid dependence." Annals of internal medicine 137, no. 8 (2002): 688-92. Abstract
"Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 17, no. 2 (2008): 116-20. Abstract
"Integrating buprenorphine treatment into office-based practice: a qualitative study." Journal of general internal medicine 24, no. 2 (2009): 218-25. Abstract
"Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study." Social science & medicine (1982) 55, no. 2 (2002): 235-46. Abstract
"Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics." Addiction science & clinical practice 11, no. 1 (2016): 1. Abstract
"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S54-61. Abstract
"The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients." Drug and alcohol dependence (2014). Abstract
"Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S62-7. Abstract
"Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial." JAMA 313, no. 16 (2015): 1636-44. Abstract
"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S33-8. Abstract
"Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department." Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 12, no. 3 (2005): 249-56. Abstract
"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence." The New England journal of medicine 355, no. 4 (2006): 365-74. Abstract
"Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients." Drug and alcohol dependence 99, no. 1-3 (2009): 132-40. Abstract
"Clinical practice. Office-based treatment of opioid-dependent patients." The New England journal of medicine 347, no. 11 (2002): 817-23.
"Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors." Journal of substance abuse treatment 35, no. 1 (2008): 87-92. Abstract
"Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms." Journal of substance abuse treatment 29, no. 4 (2005): 307-12. Abstract
"Brief intervention for hazardous and harmful drinkers in the emergency department." Annals of emergency medicine 51, no. 6 (2008): 742-750.e2. Abstract
"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 19, no. 1 (2010): 53-8. Abstract
